vimarsana.com

Latest Breaking News On - Arthritis research - Page 6 : vimarsana.com

Now What? How To Approach Your Mild Or Early AxSpA

How To Assemble A Care Team For Axial Spondyloarthritis

7 Ginkgo Biloba Benefits, Side Effects & Dosage 2024

Ixekizumab Demonstrates Consistent Safety Profile in Long-Term Analysis

Results revealed a consistent safety profile with low rates of discontinuation and no increase in adverse events with prolonged treatment exposure in patients treated with ixekizumab.

Hyperuricemia Subtype May Help Predict Response to Febuxostat in Patients With Gout

Researchers assessed the safety and efficacy of febuxostat dose escalation among patients with gout according to hyperuricemia clinical subtype. Among patients with gout, those with combined subtype hyperuricemia exhibited a lower response to febuxostat vs patients with overload or underexcretion subtypes.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.